Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004;2004(1):35-40.
doi: 10.1155/S1110724304305012.

Three-Dimensional Culture of Hybridoma Cells Secreting Anti-Human Chorionic Gonadotropin by a New Rolling Culture System

Three-Dimensional Culture of Hybridoma Cells Secreting Anti-Human Chorionic Gonadotropin by a New Rolling Culture System

Yan Wang et al. J Biomed Biotechnol. 2004.

Abstract

Cell growth rate and production of monoclonal antibody (MAb) of hybridoma cells producing anti-human chorionic gonadotropin (hCG) MAb have been used as investigation criteria in double-mouthed rolling bottle (DMRB). Compared with T-flask cell culture, both of the cell number and MAb production increased by approximately 42.5% when the medium was supplemented with 5% fetal calf serum (FCS) and DMRB rotated at 2 turns per minute. Yield of MAb was experimentally related to the number of viable cells. Interestingly, MAb yield was four times as high as that cultured in T-flask in the first 24 hours, and about 75% yield of total MAb was secreted by 48 hours during the culture. It appears that the promoted cell growth and MAb yield are resulted from the three-dimensional growth of hybridoma cells under a suitably revolving condition.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagram of a DMRB for culture of hybridoma cells. The cured surface of the bottle touches on the rolling spindles horizontally and rotates at a suitable revolution speed. It is placed in an incubator during cell culture.
Figure 2
Figure 2
Cell growth status of murine hybridoma cells perching on microcarriers. The DMEM medium was supplemented with 50 μM gentamycin, at pH 7.4 (adjusted with 7.4% NaHCO3 when necessary). Viable cells were seeded at a density of 1.5–2 × 105/mL for both T-flasks (50 mL, 25 cm2 containing 10 mL of medium) and DMRBs (containing 10 mL of medium). Microcarrier beads (0.3 g/100 mL medium) were added to the medium and cells were allowed to grow in DMEM medium (5% CO2, at 37°C) with 1%, 5%, and 10% FCS, respectively. Cells were cultured in static DMRBs supplemented with 10% FCS for 72 hours. Cells growing in T-flask were as control (bar = 0.1 mm). For rotating DMRB culture (supplemented with 10% FCS), cells were under a revolution speed of 2 turns/min for 72 hours. For each experiment, three bottles, at least, were as a group.
Figure 2
Figure 2
Cell growth status of murine hybridoma cells perching on microcarriers. The DMEM medium was supplemented with 50 μM gentamycin, at pH 7.4 (adjusted with 7.4% NaHCO3 when necessary). Viable cells were seeded at a density of 1.5–2 × 105/mL for both T-flasks (50 mL, 25 cm2 containing 10 mL of medium) and DMRBs (containing 10 mL of medium). Microcarrier beads (0.3 g/100 mL medium) were added to the medium and cells were allowed to grow in DMEM medium (5% CO2, at 37°C) with 1%, 5%, and 10% FCS, respectively. Cells were cultured in static DMRBs supplemented with 10% FCS for 72 hours. Cells growing in T-flask were as control (bar = 0.1 mm). For rotating DMRB culture (supplemented with 10% FCS), cells were under a revolution speed of 2 turns/min for 72 hours. For each experiment, three bottles, at least, were as a group.
Figure 2
Figure 2
Cell growth status of murine hybridoma cells perching on microcarriers. The DMEM medium was supplemented with 50 μM gentamycin, at pH 7.4 (adjusted with 7.4% NaHCO3 when necessary). Viable cells were seeded at a density of 1.5–2 × 105/mL for both T-flasks (50 mL, 25 cm2 containing 10 mL of medium) and DMRBs (containing 10 mL of medium). Microcarrier beads (0.3 g/100 mL medium) were added to the medium and cells were allowed to grow in DMEM medium (5% CO2, at 37°C) with 1%, 5%, and 10% FCS, respectively. Cells were cultured in static DMRBs supplemented with 10% FCS for 72 hours. Cells growing in T-flask were as control (bar = 0.1 mm). For rotating DMRB culture (supplemented with 10% FCS), cells were under a revolution speed of 2 turns/min for 72 hours. For each experiment, three bottles, at least, were as a group.
Figure 3
Figure 3
Comparison of cell growth in DMRBs and T-flasks. Total (left) and viable (right) numbers of hybridoma cells cultured in both DMRBs and T-flasks in medium containing 10% (a), 5% (b), and 1% (c) FCS, respectively. The black curve represents cell number in DMRBs and the red curve represents cell number in T-flasks. Each point is the mean of three independent parallel cultures. Vertical bars are SDs.
Figure 3
Figure 3
Comparison of cell growth in DMRBs and T-flasks. Total (left) and viable (right) numbers of hybridoma cells cultured in both DMRBs and T-flasks in medium containing 10% (a), 5% (b), and 1% (c) FCS, respectively. The black curve represents cell number in DMRBs and the red curve represents cell number in T-flasks. Each point is the mean of three independent parallel cultures. Vertical bars are SDs.
Figure 3
Figure 3
Comparison of cell growth in DMRBs and T-flasks. Total (left) and viable (right) numbers of hybridoma cells cultured in both DMRBs and T-flasks in medium containing 10% (a), 5% (b), and 1% (c) FCS, respectively. The black curve represents cell number in DMRBs and the red curve represents cell number in T-flasks. Each point is the mean of three independent parallel cultures. Vertical bars are SDs.
Figure 4
Figure 4
Comparison of MAb production rates between rolling DMRBs and T-flasks. The MAb concentrations are measured in the medium supplemented with 5% FCS in both DMRBs and T-flasks. (a) Accumulated MAb production. (b) Daily MAb production. The values are mean ± SD of three independent experiments. Vertical bars are SDs.
Figure 4
Figure 4
Comparison of MAb production rates between rolling DMRBs and T-flasks. The MAb concentrations are measured in the medium supplemented with 5% FCS in both DMRBs and T-flasks. (a) Accumulated MAb production. (b) Daily MAb production. The values are mean ± SD of three independent experiments. Vertical bars are SDs.

References

    1. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495–497. - PubMed
    1. Voigt A, Zintl F. Hybridoma cell growth and anti-neuroblastoma monoclonal antibody production in spinner flasks using a protein-free medium with microcarriers. J Biotechnol. 1999;68(2-3):213–226. - PubMed
    1. Boyd J.E, James K. Human monoclonal antibodies: their potential, problems, and prospects. In: Mizrahi A, editor. Monoclonal Antibodies: Production and Application. New York, NY: Alan R. Liss Inc; 1989. pp. 1–43. - PubMed
    1. Falkenberg F.W, Weichert H, Krane M, et al. In vitro production of monoclonal antibodies in high concentration in a new and easy to handle modular minifermenter. J Immunol Methods. 1995;179(1):13–29. - PubMed
    1. Sjörgren-Jansson E, Jeanson S. Growing hybridomas in dialysis tubing, optimization of technique. In: Zola E, editor. Laboratory Methods in Immunology. Boca Raton, Fla: CRC Press; 1990. pp. 1–41.

LinkOut - more resources